Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Algonomics
Algonomics Receives EUR 0.9 Million 1.2 M$ Research Funding from the Flemish Government
May 15th, 2009
Today, Algonomics announced it receives EUR 0.9 million (approx. USD 1.2 million) research funding from the Flemish Institute for the Promotion of Innovation by Science and Technology (IWT). Under the research program, Algonomics will collaborate with the research groups of Dr. Soren Buus (University of Copenhagen, DK) and Dr. Roberto Mallone (Inserm, FR). This 2 year funding will drive further development of Algonomics’ Epibase® platform for predictive immunogenicity of biotherapeutics. Epibase® is broadly used in the biopharma industry to estimate the relative risk to observe an immune response against protein therapeutics. Dr. Soren Buus, head of the laboratory of...
Source: Health Business Week (2009-05-15)
|